A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation

BACKGROUND: New-onset diabetes mellitus after transplantation (NODAT), a frequent and serious complication after transplantation, is associated with decreased graft and patient survival. Currently, it is diagnosed and treated primarily according to existing guidelines for type II diabetes. To date,...

Descripción completa

Detalles Bibliográficos
Autores principales: Haidinger, Michael, Werzowa, Johannes, Voigt, Hans-Christian, Pleiner, Johannes, Stemer, Gunar, Hecking, Manfred, Döller, Dominik, Hörl, Walter H, Weichhart, Thomas, Säemann, Marcus D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984585/
https://www.ncbi.nlm.nih.gov/pubmed/20925938
http://dx.doi.org/10.1186/1745-6215-11-91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984585/
https://www.ncbi.nlm.nih.gov/pubmed/20925938
http://dx.doi.org/10.1186/1745-6215-11-91

Ejemplares similares